RBC Capital Starts Corbus Pharmaceuticals (CRBP) at Outperform, 'Reinventing Themselves With Promising ADC and Obesity Assets'
Tweet Send to a Friend
(Updated - May 13, 2024 5:04 AM EDT)
RBC Capital analyst Brian Abrahams initiates coverage on Corbus Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams initiates coverage on Corbus Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
